| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 07/29/2004 | WO2004063190A1 Fused heterocyclic derivates as ppar modulators |
| 07/29/2004 | WO2004063177A1 Benzoxazole derivatives and their use as adenosine receptor ligands |
| 07/29/2004 | WO2004063176A1 Process for the recovery of oxazole |
| 07/29/2004 | WO2004063175A1 A novel and an improved process for the preparation of (s)-4-(4-aminobenzyl)-2- oxazolidinone |
| 07/29/2004 | WO2004063155A1 Fused heterocyclic derivatives as ppar modulators |
| 07/29/2004 | WO2004062601A2 Antibacterial agents |
| 07/29/2004 | WO2004046091A3 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/29/2004 | US20040147760 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| 07/29/2004 | US20040147758 Compounds for treatment of AIDS with enzyme inhibitors |
| 07/29/2004 | US20040147755 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 07/29/2004 | US20040147569 Cell differentiation inducer |
| 07/29/2004 | US20040147560 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 07/29/2004 | US20040147503 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; antitumor agents; glomerulonephritis |
| 07/29/2004 | US20040147454 Aspartyl protease inhibitors |
| 07/29/2004 | CA2851462A1 Antibacterial agents |
| 07/29/2004 | CA2516408A1 Process for the recovery of oxazole |
| 07/29/2004 | CA2512602A1 Benzoxazole derivatives and their use as adenosine receptor ligands |
| 07/29/2004 | CA2512582A1 Antibacterial agents |
| 07/29/2004 | CA2510516A1 Fused heterocyclic derivatives as ppar modulators |
| 07/29/2004 | CA2509202A1 Fused heterocyclic derivatives as ppar modulators |
| 07/28/2004 | EP1439885A1 Simplified sarcodictyn derivatives as anti-tumor agents |
| 07/28/2004 | EP1058698B1 Preparation for prevention and healing of inflammation affections |
| 07/28/2004 | CN1516694A 2-(2,6-disubstituted phenyl)-4-aryl-5-alkyl-1,3-oxazoline compounds useful as insecticides and acaricides |
| 07/28/2004 | CN1515562A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515561A Method for producing chiral succinic acid derivative |
| 07/28/2004 | CN1515559A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515248A Urea derivative used as inosine-5'-dehydrogenase monophosphate inhibitor |
| 07/28/2004 | CN1159292C Aryl substitued cyclic amines as selective dopamine D3 ligands |
| 07/28/2004 | CN1159278C Fungicidal methods, compounds and compositions contg. benzophenones |
| 07/27/2004 | US6767864 Pesticides, herbicides |
| 07/22/2004 | WO2004060881A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof |
| 07/22/2004 | WO2004037773A8 Phenethanolamine derivative for the treatment of respiratory diseases |
| 07/22/2004 | US20040143131 in particular,manufacturing a 5-(tert-butylcarbamoyl)-aminomethyl-oxazolidinone by condensing a carbamate with a tert-butylcarbamoyl protected derivative of glycidylamine or 3-amino-1-halopropanol, intermediates |
| 07/22/2004 | US20040142999 Novel compounds and compositions as cathepsin inhibitors |
| 07/22/2004 | US20040142991 Therapy for immunology diseases; antiinflammatory agents; obesity; hyperlipemic agents; hypotensive agents; central nervous system disorders; antidiabetic agents |
| 07/22/2004 | US20040142986 Controlling transforming growth facor; artificial skin; wound healing agents |
| 07/22/2004 | US20040142985 Heterocyclic compounds useful to treat HCV |
| 07/22/2004 | US20040142980 Viricides; hepatitis virus infections |
| 07/22/2004 | US20040142953 Inhibitors of histone deacetylase |
| 07/22/2004 | US20040142939 antimicrobials with activity against human and veterinary pathogens: Gram-positive aerobic bacteria multiply-resistant staphylococci and streptococci, anaerobic organisms bacteroides and clostridia and acid-fast organisms such as Mycobacterium |
| 07/22/2004 | US20040142206 substituted with aromatic groups, e.g., 2,2'-dihexyloxy-6,6'dianthracenyl- (or 6,6'-dipyrenyl-) 1,1'-binaphthylene; good solubility in common organic solvents, resist crystallization and can be sublimed in a device fabrication process. |
| 07/21/2004 | EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR |
| 07/21/2004 | EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/21/2004 | EP1438288A1 Substituted thioacetamides |
| 07/21/2004 | EP0932402B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 07/21/2004 | CN1513847A Multidentate oxazoline ligand having chirality and its compounding product with main group metal or transition metal, synthesis method and its use |
| 07/21/2004 | CN1158286C Taxane derivatives and processes for preparation thereof |
| 07/20/2004 | US6765100 Method for producing epoxide crystal |
| 07/20/2004 | US6765023 Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 07/20/2004 | US6765021 Antidiabetic agents |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | CA2257136C Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/15/2004 | WO2004058732A1 Oxazolidine derivative, methods of preparation and uses |
| 07/15/2004 | WO2004058723A1 Biphenyl derivatives and their use as fungicides |
| 07/15/2004 | WO2004058679A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 07/15/2004 | WO2004058174A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 07/15/2004 | WO2004052887A3 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 07/15/2004 | WO2004046122A3 Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | US20040138502 Ph-dependent nmda receptor antagonists |
| 07/15/2004 | US20040138462 Aminoalcohol derivatives |
| 07/15/2004 | US20040138277 Syndrome X, hyperglycemia, hyperlipidemia, obesity, atherosclerosis; anticoagulant, hypotensive, and antidiabetic agents; cardiovascular disorders |
| 07/15/2004 | US20040138274 Novel pharmaceuticals |
| 07/15/2004 | US20040138265 Carboxamides as fungicides in agriculture |
| 07/15/2004 | US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis |
| 07/15/2004 | US20040138213 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient |
| 07/15/2004 | US20040138205 Viricides; hepatitis virus |
| 07/15/2004 | US20040138160 Administering tyrosine kinase inhibitor; suppression signal; blocking her gene |
| 07/15/2004 | CA2511178A1 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 07/14/2004 | EP1437346A1 Benzamide derivatives useful as cell differentiation inducers |
| 07/14/2004 | EP1436258A2 Ph-dependent nmda receptor antagonists |
| 07/14/2004 | EP1435964A2 Novel prodrugs of n-h bond-containing compounds and methods of making thereof |
| 07/14/2004 | EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 07/14/2004 | EP1435951A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 07/14/2004 | EP1435946A2 Linked biaryl compounds |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/14/2004 | CN1512880A Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | CN1511833A Process for preparing isoxazolyl alkyl diketone compound |
| 07/14/2004 | CN1511832A Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1157368C Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR)a |
| 07/13/2004 | US6762326 C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 07/13/2004 | US6762277 Method of manufacturing N-carboxyamino acid anhydride and polyamino acid |
| 07/13/2004 | US6762257 Forming telechelic polymers |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762199 Ability to modulate the interaction of the ligand vcam-1 with its integrin receptor alpha 4 beta 1; treatment of inflammation, atherosclerosis, autoimmune disease |
| 07/13/2004 | US6762198 Such as 2-((4'-methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl)-amino-3-(2-phenoxymethyl -(1,3)dioxan-2-yl)propionic acid |
| 07/13/2004 | US6762152 Four to seven membered heterocycles substituted on benzene ring; reaction of a ketone with a substituted benzoic acid |
| 07/08/2004 | WO2004056787A1 Cyclopentyl glutaramides and their use as neutral endopeptidase inhibitors |
| 07/08/2004 | WO2004056740A1 Dicarboxylic acid derivatives as ppar-agonists |
| 07/08/2004 | WO2004056315A2 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 07/08/2004 | WO2004041755A3 Quinazolinone compounds as calcilytics |
| 07/08/2004 | WO2004032882A3 Chemical compounds |
| 07/08/2004 | WO2004022060A3 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders |
| 07/08/2004 | WO2004009017A3 Modulators of the glucocorticoid receptor and method |
| 07/08/2004 | WO2003103599A3 Caspase-1 inhibitors and methods for their use |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132791 N-(on SO2 ) (2-hydroxy-3-substituted aminopropyl)-substituted; inhibiting retroviral replication |
| 07/08/2004 | US20040132788 thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives; treating neurodegenerative disorders or pain. |